Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
8.15
+0.07 (0.87%)
Feb 4, 2026, 3:04 PM CST
SHE:300636 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 242.54 | 176.38 | 512.75 | 141.96 | 161.29 | 280.4 |
Short-Term Investments | 574.64 | 194.58 | 64.49 | - | - | - |
Trading Asset Securities | 0.3 | 20.05 | - | - | - | - |
Cash & Short-Term Investments | 817.48 | 391.02 | 577.24 | 141.96 | 161.29 | 280.4 |
Cash Growth | 165.45% | -32.26% | 306.61% | -11.98% | -42.48% | 632.77% |
Accounts Receivable | 120.26 | 96.49 | 70.87 | 94.69 | 60.11 | 20.36 |
Other Receivables | 4.17 | 6.12 | 6.43 | 1.27 | 35.28 | 24.4 |
Receivables | 124.43 | 102.61 | 77.3 | 95.96 | 95.4 | 44.76 |
Inventory | 533.23 | 552.51 | 523.42 | 497.36 | 373.42 | 335.41 |
Prepaid Expenses | - | 0.32 | 0.54 | 2.28 | 0.01 | - |
Other Current Assets | 15.25 | 4.57 | 18.48 | 20.39 | 13.44 | 4.62 |
Total Current Assets | 1,490 | 1,051 | 1,197 | 757.95 | 643.56 | 665.2 |
Property, Plant & Equipment | 1,682 | 1,490 | 1,514 | 1,422 | 1,218 | 754.68 |
Long-Term Investments | 54.61 | 724.42 | 488.84 | - | - | - |
Other Intangible Assets | 18.85 | 19.28 | 20.17 | 21.08 | 21.43 | 22.03 |
Long-Term Deferred Tax Assets | 0.24 | 0.11 | 0.23 | 0.13 | 0.15 | 0.09 |
Other Long-Term Assets | 12.55 | 34.52 | 1.09 | 57.96 | 24.05 | 25.66 |
Total Assets | 3,258 | 3,320 | 3,221 | 2,259 | 1,907 | 1,468 |
Accounts Payable | 154.78 | 150.36 | 130.39 | 212.82 | 143.78 | 30.89 |
Accrued Expenses | 22.09 | 31.36 | 24.8 | 21.13 | 17.84 | 13.08 |
Short-Term Debt | 140.68 | 300.8 | 429.31 | 267.83 | 182.29 | 209.37 |
Current Portion of Long-Term Debt | 252.02 | 1.31 | 86.55 | 16 | 4 | - |
Current Portion of Leases | - | 1.11 | 1.06 | 1.06 | 1.06 | - |
Current Income Taxes Payable | 1.51 | - | 0.03 | - | 0.05 | 0.04 |
Current Unearned Revenue | 5.12 | 4.24 | 2.09 | 11.69 | 10.03 | 3.48 |
Other Current Liabilities | 6.35 | 16.66 | 27.47 | 44.51 | 1.61 | 1.25 |
Total Current Liabilities | 582.56 | 505.84 | 701.71 | 575.04 | 360.67 | 258.11 |
Long-Term Debt | 190.1 | 398.5 | 250 | 326.33 | 619.63 | 365.6 |
Long-Term Leases | 0.37 | 1.03 | 2.04 | 2.91 | 3.79 | - |
Long-Term Unearned Revenue | 57.76 | 62.35 | 4.02 | 4.03 | 4.19 | 4.35 |
Long-Term Deferred Tax Liabilities | 51.76 | 43.08 | 37.22 | 30.88 | 30.34 | 23.11 |
Total Liabilities | 882.54 | 1,011 | 994.99 | 939.19 | 1,019 | 651.17 |
Common Stock | 419.95 | 421.53 | 423.14 | 350.19 | 205.91 | 128.62 |
Additional Paid-In Capital | 1,241 | 1,252 | 1,271 | 543.38 | 251.54 | 327.16 |
Retained Earnings | 714.66 | 647.6 | 557.74 | 467.52 | 379.83 | 309.65 |
Treasury Stock | - | -12.34 | -25.18 | -41.42 | - | - |
Comprehensive Income & Other | - | - | - | - | 50.83 | 51.07 |
Shareholders' Equity | 2,376 | 2,309 | 2,226 | 1,320 | 888.11 | 816.5 |
Total Liabilities & Equity | 3,258 | 3,320 | 3,221 | 2,259 | 1,907 | 1,468 |
Total Debt | 583.17 | 702.75 | 768.96 | 614.13 | 810.78 | 574.97 |
Net Cash (Debt) | 234.32 | -311.74 | -191.72 | -472.17 | -649.48 | -294.57 |
Net Cash Per Share | 0.56 | -0.74 | -0.50 | -1.36 | -1.92 | -0.95 |
Filing Date Shares Outstanding | 419.95 | 420.12 | 420.58 | 346.66 | 308.86 | 308.69 |
Total Common Shares Outstanding | 419.95 | 420.12 | 420.58 | 346.66 | 308.86 | 308.69 |
Working Capital | 907.83 | 545.19 | 495.27 | 182.91 | 282.89 | 407.09 |
Book Value Per Share | 5.66 | 5.50 | 5.29 | 3.81 | 2.88 | 2.65 |
Tangible Book Value | 2,357 | 2,289 | 2,206 | 1,299 | 866.68 | 794.47 |
Tangible Book Value Per Share | 5.61 | 5.45 | 5.25 | 3.75 | 2.81 | 2.57 |
Buildings | - | 471.6 | 427.23 | 346.16 | 230.51 | 162.72 |
Machinery | - | 1,288 | 925.85 | 578.62 | 555.63 | 457.18 |
Construction In Progress | - | 186.23 | 503.08 | 772.97 | 641.34 | 306.99 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.